ArticleAnnals of clinical microbiology and antimicrobials2016
De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.
Song Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.